Encompass Health Corporation $EHC Stock Acquired by Inspire Investing LLC

Inspire Investing LLC grew its holdings in Encompass Health Corporation (NYSE:EHC) by 66.1% in the 3rd quarter, HoldingsChannel reports. The firm owned 65,010 shares of the company’s stock after purchasing an additional 25,878 shares during the quarter. Inspire Investing LLC’s holdings in Encompass Health were worth $7,898,000 as of its most recent SEC filing.

Other hedge funds also recently added to or reduced their stakes in the company. Root Financial Partners LLC acquired a new position in shares of Encompass Health in the third quarter worth $52,000. Quadrant Capital Group LLC increased its position in shares of Encompass Health by 25.0% during the third quarter. Quadrant Capital Group LLC now owns 11,602 shares of the company’s stock worth $1,442,000 after acquiring an additional 2,318 shares during the period. Nisa Investment Advisors LLC raised its stake in shares of Encompass Health by 3.1% in the third quarter. Nisa Investment Advisors LLC now owns 17,501 shares of the company’s stock valued at $2,126,000 after acquiring an additional 519 shares in the last quarter. Diversify Advisory Services LLC raised its stake in shares of Encompass Health by 94.6% in the third quarter. Diversify Advisory Services LLC now owns 10,758 shares of the company’s stock valued at $1,374,000 after acquiring an additional 5,231 shares in the last quarter. Finally, Fort Washington Investment Advisors Inc. OH raised its stake in shares of Encompass Health by 19.8% in the third quarter. Fort Washington Investment Advisors Inc. OH now owns 281,075 shares of the company’s stock valued at $34,148,000 after acquiring an additional 46,512 shares in the last quarter. 97.25% of the stock is currently owned by institutional investors and hedge funds.

Insider Activity at Encompass Health

In other Encompass Health news, CEO Mark J. Tarr sold 173,148 shares of the firm’s stock in a transaction that occurred on Monday, August 10th. The shares were sold at an average price of $125.47, for a total transaction of $21,724,879.56. Following the sale, the chief executive officer owned 267,814 shares of the company’s stock, valued at approximately $33,602,622.58. This trade represents a 39.27% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. Also, EVP John Darby sold 4,858 shares of the firm’s stock in a transaction that occurred on Monday, August 31st. The stock was sold at an average price of $121.09, for a total transaction of $588,255.22. Following the sale, the executive vice president directly owned 75,041 shares in the company, valued at approximately $9,086,714.69. The trade was a 6.08% decrease in their position. The SEC filing for this sale provides additional information. In the last 90 days, insiders have sold 186,912 shares of company stock valued at $23,434,845. 1.80% of the stock is owned by company insiders.

Encompass Health Price Performance

Encompass Health stock opened at $124.23 on Friday. The company has a current ratio of 1.19, a quick ratio of 1.19 and a debt-to-equity ratio of 0.76. The company has a fifty day simple moving average of $122.35 and a 200-day simple moving average of $112.46. The stock has a market cap of $12.26 billion, a P/E ratio of 20.23, a price-to-earnings-growth ratio of 2.55 and a beta of 0.74. Encompass Health Corporation has a 12-month low of $92.77 and a 12-month high of $129.96.

Encompass Health (NYSE:EHC) last posted its earnings results on Wednesday, August 5th. The company reported $1.55 EPS for the quarter, beating the consensus estimate of $1.48 by $0.07. Encompass Health had a return on equity of 18.08% and a net margin of 10.01%. The firm had revenue of $1.60 billion for the quarter, compared to analyst estimates of $1.57 billion. During the same quarter in the prior year, the company posted $1.40 earnings per share. Encompass Health’s revenue for the quarter was up 9.6% compared to the same quarter last year. Encompass Health has set its FY 2026 guidance at 6.020-6.250 EPS. Equities analysts expect that Encompass Health Corporation will post 6.08 EPS for the current fiscal year.

Encompass Health Announces Dividend

The firm also recently announced a quarterly dividend, which will be paid on Friday, January 15th. Investors of record on Monday, January 4th will be paid a dividend of $0.21 per share. The ex-dividend date is Monday, January 4th. This represents a $0.84 annualized dividend and a yield of 0.7%. Encompass Health’s payout ratio is presently 13.68%.

Analysts Set New Price Targets

Several research analysts recently commented on EHC shares. Truist Financial boosted their target price on Encompass Health from $140.00 to $150.00 and gave the stock a “buy” rating in a research note on Friday, August 7th. Raymond James Financial set a $150.00 price target on Encompass Health in a research report on Monday, September 28th. UBS Group increased their price target on Encompass Health from $150.00 to $155.00 and gave the company a “buy” rating in a research report on Friday, August 7th. Barclays lifted their price objective on Encompass Health from $140.00 to $144.00 and gave the company an “overweight” rating in a research note on Thursday, August 6th. Finally, Wall Street Zen downgraded Encompass Health from a “buy” rating to a “hold” rating in a research report on Saturday, October 17th. One analyst has rated the stock with a Strong Buy rating, five have assigned a Buy rating and one has given a Hold rating to the company. According to MarketBeat.com, the company currently has a consensus rating of “Buy” and a consensus price target of $148.50.

About Encompass Health

Encompass Health Corporation (NYSE:EHC) is a healthcare services company that operates inpatient rehabilitation hospitals in the United States and Puerto Rico. Its hospitals provide intensive rehabilitation to patients recovering from conditions such as stroke, brain and spinal cord injuries, neurological disorders, amputations, hip fractures and other serious illnesses or injuries.

The company’s services typically include nursing care, physical therapy, occupational therapy, speech and language therapy, respiratory therapy and medical management.